offline
(25.03.2019, 17:06)Ventura schrieb:(25.03.2019, 17:02)bimbes schrieb:(24.03.2019, 13:22)bimbes schrieb:(23.03.2019, 13:42)Ventura schrieb: Biogen
A common measure of a stock’s relative value is the multiple of its price to estimated earnings per share. At its current price of $226 a share, Biogen is trading at a multiple of about eight times earnings. It will take a decline of about 10 percent to put Biogen in the bargain bin.
“Everyone is trying to understand where the floor is,” said Suneja, the Guggenheim analyst.
That could take a while. Like I said, not for the faint of heart.
https://www.bostonglobe.com/business/201...story.html
in einem MOnat Wissen wir mehr
http://investors.biogen.com/news-release...il-24-2019
es wird auch ohne Alzheimer Disease weiter gehen
http://investors.biogen.com/static-files...e770386d6e
weiter geht es:
Biogen kündigt 5 billion USD Aktienrückkauf an, zusätzlich zu dem bestehendem Programm aus 2018 (mit 1,7 bill)
https://www.sec.gov/Archives/edgar/data/...chases.htm
you made my day!
Meine Pos ist etwas zu groß...
nach Finviz ist die Marktkap ca. 44,63 bill
6,17 bill ist da eine ordentliche Menge die da von der Platte genommen wird
__________________
_________________________________________________________________________________________________
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056
